Oracle JD Edwards EnterpriseOne Tools up to 9.2.8.2 Monitoring/Diagnostics SEC improper authentication
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 9.6 | $0-$5k | 0.00 |
Summary
A vulnerability described as critical has been identified in Oracle JD Edwards EnterpriseOne Tools. The impacted element is an unknown function of the component Monitoring/Diagnostics SEC. The manipulation results in improper authentication. This vulnerability is cataloged as CVE-2025-21524. The attack may be launched remotely. There is no exploit available. Upgrading the affected component is recommended.
Details
A vulnerability was found in Oracle JD Edwards EnterpriseOne Tools. It has been classified as very critical. Affected is an unknown code block of the component Monitoring/Diagnostics SEC. The manipulation with an unknown input leads to a improper authentication vulnerability. CWE is classifying the issue as CWE-287. When an actor claims to have a given identity, the product does not prove or insufficiently proves that the claim is correct. This is going to have an impact on confidentiality, integrity, and availability. CVE summarizes:
Vulnerability in the JD Edwards EnterpriseOne Tools product of Oracle JD Edwards (component: Monitoring and Diagnostics SEC). Supported versions that are affected are Prior to 9.2.9.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise JD Edwards EnterpriseOne Tools. Successful attacks of this vulnerability can result in takeover of JD Edwards EnterpriseOne Tools. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).
The advisory is available at oracle.com. This vulnerability is traded as CVE-2025-21524 since 12/25/2024. The exploitability is told to be easy. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. The technical details are unknown and an exploit is not available. The structure of the vulnerability defines a possible price range of USD $0-$5k at the moment (estimation calculated on 02/01/2025).
Upgrading to version 9.2.9.0 eliminates this vulnerability.
If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 9.8VulDB Meta Temp Score: 9.6
VulDB Base Score: 9.8
VulDB Temp Score: 9.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 9.8
CNA Vector (oracle): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Improper authenticationCWE: CWE-287
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: JD Edwards EnterpriseOne Tools 9.2.9.0
Timeline
12/25/2024 🔍01/21/2025 🔍
01/21/2025 🔍
02/01/2025 🔍
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2025-21524 (🔍)
GCVE (CVE): GCVE-0-2025-21524
GCVE (VulDB): GCVE-100-292794
Entry
Created: 01/21/2025 22:36Updated: 02/01/2025 06:25
Changes: 01/21/2025 22:36 (65), 02/01/2025 06:25 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.